Congratulations to DZNE’s Martin Dichgans, Brit Mollenhauer, @joachimschultze.bsky.social and Mikael Simons for their notable scientific impact and ongoing contributions to advancing our understanding of neurodegenerative diseases.

They are listed as Highly Cited Researchers 2025 by @clarivate.com

🏆Congrats! @cboeger.bsky.social, PhD student at DZNE, was honored with the „3rd annual Drs. Ayeez and Shelena Lalji & Family Student Scholar Award for Repair and Regenerative Mechanisms in ALS“, worth 5,000 US Dollars.

👉 www.dzne.de/en/im-fokus/...

🏆Congrats to Dr. Anna Aschenbrenner for the "Tobias Welte Prize” of the German Sepsis Society, which recognizes her research on the life-saving effects of the drug #dexamethasone in #COVID-19 patients.

👉 www.dzne.de/en/im-fokus/...

Registration open: eveeno.com/applicationb...

Under the theme “From Genes to Circuits and Behavior”, top neuroscientists - incl. Cori Bargmann, @edvardmoser.bsky.social, Rosa Paolicelli, Maude Baldwin & Zachary Knight - will meet at to explore how neural circuits drive behavior.

DZNE is joining the Human Immunome Project (HIP) as a scientific partner and a member of the project’s European hub - together with @immunosens.bsky.social and the Germany-based "Swarm Learning Consortium".

👉 www.dzne.de/en/im-fokus/...

Gratulerar! Award for groundbreaking AD research. Lars Lannfelt, one of the pioneers behind "Lecanemab", has been honored with the Hartwig-Piepenbrock-DZNE-Prize. He receives the award for his outstanding contributions to the development of new therapeutic approaches for neurodegenerative diseases.

🥂 Dr. Maria Eugenia Bernis received the 2025 GNPI Science Prize! She showed caffeine can help protect newborn brains after oxygen deprivation. In a preclinical model, just 3 days of caffeine treatment significantly reduced brain damage and inflammation by modulating the AMPK/mTOR signaling pathway.

Congratulations to Christian Haass (@haasslab.bsky.social)! He receives an honorary doctorate from the University of Eastern Finland for 30+ years of groundbreaking Alzheimer’s research on beta-amyloid proteins and new therapeutic approaches. 📸: UFE/Raija Törrönen & UFE/Niko Jouhkimainen

Woohoo!! A proud DZNE is part of three Clusters of Excellence: @neurocure.bsky.social (Berlin), @immunosens.bsky.social (Bonn), and @synergy-munich.bsky.social (Munich). These top research networks will receive 7 more years of funding from 2026. #ExcellenceStrategy #Neuroscience

📺 Video summary:

Today we celebrate International Mother Language Day @ DZNE. Language is more than communication—it’s identity, history, and connection. At our center, people from 60+ nations collaborate, bringing diverse backgrounds and tongues. For the record: Science thrives on diversity and exchange.

Congrats to these two first authors from DZNE Munich on receiving the "Best Paper Award" from the DZNE foundation! @shreeyakedia.bsky.social was honored for her paper published in “Nature Neuroscience”. Marvin Reich, received the award for his paper published in “Science Translational Medicine”.

Warm wishes for a wonderful holiday season and a New Year that’s full of creativity, inspiration, and achievement.

👏 Congrats! A DZNE research team around Prof. Martin Reuter has been awarded around one million US dollars, by NIH, for the development of an innovative, AI-based method to measure the “choroid plexus” three-dimensionally in human brain scans.

More 👉: www.dzne.de/en/news/pres...

DZNE's Markus Zweckstetter has been awarded around 2.5 million euros. His studies will focus on so-called kinases, a special class of enzymes. From the 5 year project, he and his team aim to gain insights for the development of new drugs against Alzheimer's.

More 👉: www.dzne.de/en/news/pres...

In order to support young researchers in the field of dementia research in Germany, the Frankfurt-based Hans and Ilse Breuer Foundation has awarded three doctoral scholarships to DZNE linked phd students. Read more 👉
www.dzne.de/en/im-fokus/...

Ideas need Diversity and Cooperation: That is why we take a clear stand against discrimination, racism and narrow-mindedness - and for an open, free society, for democracy and diversity.
Our full statement 👉 www.linkedin.com/feed/update/...

Hörtipp: In Kürze dürfte die EMA das #Alzheimer-Medikament Lecanemab zur Zulassung empfehlen. Was ist das für ein Mittel und wem hilft es? Was ist mit Nebenwirkungen? Ist das Mittel evtl. der Anfang einer Revolution? Mehr dazu im verlinken @zeit.de WISSEN Podcast. 👉 www.zeit.de/gesundheit/2...